Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.09%), DAX (0.14%), CAC40 (0.02%)

Jun 16 ,2026

  • Synopsis

    • European equity markets are set to open slightly lower, while Asian equities mixed Tuesday. South Korea outperforming with memory giants taking cues from rally in US. Gains picking up in Japan and Taiwan. Greater China mixed with losses in Hong Kong balanced by strength in mainland.

    • Latest UK political news suggests leadership hopeful Burnham will give Starmer space to resign after by-election rather than immediately trigger a leadership contest. European leaders to press Trump on details of Iran deal. Press reports said allies worried that US negotiating team may fail to secure a robust nuclear agreement or address Iran's ballistic missile program. UK set to announce fresh Russian sanctions and extend energy support to Ukraine.

    • On today's agenda, EU General Affairs Council includes a policy debate on a draft negotiating box regarding the new MFF 2028-34. Meeting of EU health minister. In the UK, there are MPs questions on foreign, Commonwealth and development followed by the remaining stages of the Cyber Security and Resilience (Network and Information Systems) Bill. Committee topics include OBR at 9:45BST (HM Treasury execs), relationship between the Government and the defence industry at 11:00, trade in a turbulent world: how should the UK deploy its trade instruments? At 14:00, AI, business and the future of the workforce at 14:30. Other political events include EU's Kadis participating in the 11th Our Ocean Conf (through Thu), EU's Dombrovskis participates in the EP Plenary for question time on "State of play on the European Commission's pledge to reduce the reporting burden, in particular for SMEs", 8th European Nuclear Safety Conf (through Wed), The Economist hosts annual Commercialising Quantum Global 2026 conf (through Wed) and FT Global Bond Summit (through Wed). Fitch Ratings Global Bank Regulation Mid-Year 2026 webinar at 8:30BST and at 15:00. Also on Tue, Unicredit's (UCG.IM) takeover offer for Commerzbank (CBK.GR) currently due run until midnight and Reaktor Group (REAKTOR.FH) first day of trading.

    • In central banks, ECB's Machado in roundtable discussion at 9:00CET at DigitalEurope Finance Executive Council Summer Summit. BOE's Khan speech at 10:00BST at Airmic annual conf. Bank of Spain's Escrivá speech at 12:55CET at the presentation of the report "Banking Union: Between Geopolitics and Simplification." ECB's Lane in conversation at 14:10BST at Reuters NEXT Europe. Austria central bank's Kocher continues series of public meetings at 17:00CET where citizens can ask him their questions about money and the economy. Latvia central bank's Rutkaste in a discussion on LTV and the bank also presents the latest economic forecasts. Netherland central bank's Sleijpen speech at Centre for European Reform. Ireland central bank's Makhlouf speech to European Chamber of Ireland and Diplomatic Community, the bank also hosts a hybrid event for the (re)insurance industry on the Solvency II Review and IRRD.

    • Overseas, BoJ raised policy rate by 25 bps to 1.00% as expected. Said will continue to reduce monthly bond purchases by JPY200B per quarter, leaving monthly pace at around JPY2T from April-2027. RBA left cash rate unchanged at 4.35% in unanimous vote. Said prepared to raise rates further to meeting price stability and full employment mandate. China activity data mixed. Better industrial production number, but retail sales contraction worse than expected and fixed asset investment missed. Property metrics were also weak.

    • European macro data releases out today include Germany Jun ZEW survey, Italy May final CPI, and UK Jun house price index - Rightmove.

    • In corporate news, yesterday after the markets closed Securitas (SECU.B.SS) issued a presentation detailing its 2030 strategy together with updated financial targets ahead on its Capital Markets Day on 16-Jun. Elswhere, Aeroport de Paris (ADP.FP) and Flughafen Wien (FLU.AV) released May traffic figures. In France, Biophytis (ALBPS.FP) trading suspended due to non-publication of FY25 financial report with publication expected no later than end of July.

  • Politics/Macro/World News

    • Trump declares US-Iran peace deal 'all signed' as G7 leaders battle to tie up loose ends - The Guardian

    • Strait of Hormuz flow will take 'weeks' to resume, largest tanker operator warns - FT

    • Burnham's UK Industrial Revival Plan Unlikely to Bring Back Jobs - Bloomberg

    • Swiss Lean in Favor of EU Deal After Dismissing Population Cap - Bloomberg

    • Trump snubs Starmer plea for Anthropic AI exemption - The Telegraph

  • Top company news

    • Earnings/updates

      • ADP.FP (Aeroport de Paris) -- reports Total Paris Aeroport May traffic 9.49M, +1% y/y

      • SECU.B.SS (Securitas) -- presents its 2030 strategy together with updated financial targets

      • ALBPS.FP (Biophytis) -- Trading suspended in Biophytis due to non-publication of FY25 financial report; publication expected no later than end of July

      • ALVU.FP (Vente-Unique.com) -- reports H1 net income €5.0M vs year-ago €4.9M

      • CICN.SW (Cicor Technologies) -- divests Tunisia facility; expects mid-single-digit CHF million one-time costs; FY26 financial guidance confirmed

      • FLU.AV (Flughafen Wien) -- reports May Group total passenger traffic +0.7% to 3.91M

      • Also reporting today includes:

        • Earnings:

          • Benelux: Colruyt Group (COLR.BB)

          • France: MedinCell (MEDCL.FP)

          • UK: MHP (MHPC.LN), Tatton Asset Management (TAM.LN), Accsys Technologies (AXS.LN), IG Design Group (IGR.LN)

        • Trading Update:

          • Nordics: Borregaard (BRG.NO)

          • UK: Sthree (STEM.LN)

        • CMD/Events: Equinor (EQNR.NO), NOS (NOS.PL), EDP.PL (EDP-Energias de Portugal), Renishaw (RSW.LN), WashTec (WSU.GR), Theon International (THEON.NA), Verve Group (VER.SS), Adocia (ADOC.FP) investor meeting - Key Opinion Leader, Enento Group (ENENTO.FH) pre-close call, Ferrovial (FER.SM) TCI Fund Management's Investors Day, Volvo Cars (VOLCAR.B.SS) pre-close call,

    • M&A

      • OR.FP (L'Oreal) -- Canada subsidiary acquires all assets of Cantin Beaute; terms not disclosed

      • ISP.IM (Intesa Sanpaolo) -- commits to consulting with Italy's government over future decisions impacting Generali - Reuters (15-Jun, 17:21 CEST)

      • EDEN.FP (Edenred) -- to acquire The Mobility House Solutions; financial terms not disclosed

      • FRVIA.FP (Forvia) -- FTC grants antitrust clearance for Apollo Funds' purchase of Forvia's Interiors group

      • PSM.GR (ProSiebenSat.1 Media) -- Jochen Schweizer exploring buying back adventure-experience business from ProSiebenSat.1 - Reuters

      • BKT.SM (Bankinter) -- to acquire Tulp Hypotheken; terms not disclosed

      • FRAS.LN (Frasers Group) -- running same takeover playbook in two different venues - The Australian

      • KEMIRA.FH (Kemira) -- acquires Clear Water Technologies, LLC; price not disclosed

      • CICN.SW (Cicor Technologies) -- divests Tunisia facility; expects mid-single-digit CHF million one-time costs; FY26 financial guidance confirmed

      • BEN.FP (Beneteau) -- announces targeted adaptation of US activities in a market affected by Middle East Conflict; planned divestiture of Cadillac Shipyard and Four Winns, Glastron and Scarab Jet brands

    • Healthcare

      • REGN (Regeneron) -- NICE recommends Regeneron's Libtayo with platinum-based chemotherapy for untreated advanced NSCLC

      • LONN.SW (Lonza Group) -- Lonza issues exclusive, target-specific license to Antharis Therapeutics to advance dual payload ADCs for gastrointestinal cancers

      • RYTM (Rhythm Pharmaceuticals) -- announces multiple new data presentations from MC4R agonists in acquired hypothalamic obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026

      • FARN.LN (Faron Pharmaceuticals) -- Transcript Intelligence: Faron Pharmaceuticals Business Update Call

    • Other

      • ETL.FP (Eutelsat Communications) -- Eutelsat and French Armed Forces Ministry announce call-off capacity contract for the NEXUS Framework agreement

      • WAF.GR (Siltronic) -- AG successfully places 3.0M new shares in the amount of 10% of the share capital at €91 per share

      • WAF.GR (Siltronic) -- launches cash capital increase

      • THEON.NA (Theon International) -- Theon announces MoU with Safran to establish JV for electro-optical solutions for drones

      • DSFIR.NA (DSM-Firmenich) -- releases 2025 sustainability report

      • VK.FP (Vallourec) -- Transcript Intelligence: Vallourec Business Update Call

      • BEIJ.B.SS (Beijer Ref) -- Breeze announces its intention to sell ~30.7M class B shares in Beijer Ref, equivalent to ~6.0% of the company

      • ConocoPhillips set to sign contract with Syria's new government to revive gas production - Reuters, citing FT

  • Key rating changes

    • Upgrades

      • CURY.LN (Currys) -- to outperform from sector perform at RBC Capital Markets

      • P911.GR (Porsche) -- to equal weight from underweight at Barclays

    • Downgrades

      • SFZN.SW (Siegfried Holding) -- to neutral from buy at UBS

      • APAM.NA (Aperam) -- to equal-weight from overweight at Morgan Stanley

      • HUBN.SW (HUBER+SUHNER) -- to hold from buy at Berenberg

      • FRAS.LN (Frasers Group) -- to underperform from sector perform at RBC Capital Markets

      • SMG.SW (SMG Swiss Marketplace Group) -- to neutral from overweight at JPMorgan

      • BWLPG.NO (BW LPG) -- to hold from buy at Pareto

    • Initiations

      • ASSA.B.SS (Assa Abloy) -- outperform at RBC Capital Markets

  • Data

    • Nikkei +0.13% to 69409.23

    • Hang Seng (1.62%) to 24439.44

    • Shanghai Composite (0.36%) to 4081.70

    • S&P futures (7.3) vs prior close of 7626.5

    • €-$ (0.0016) or (0.14%) to 1.1576

    • $-¥ (0.04) or (0.03%) to 160.30

    • €-¥ (0.29) or (0.16%) to 185.54

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.